According to the report, titled, “Ophthalmic Femtosecond Lasers Market Size, Share and Global Trend By Product (Equipment, Consumables and accessories), By Application (Refractive Surgery, Cataract Surgery, Keratoplasty, Pocket Creation, Intracorneal Rings, Incisions & Flap Cuts), By Type of Cells (Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Eye Institutes) and Geography Forecast till 2026”, the cataract surgery segment is currently dominating the market and anticipated to continue dominant in the forecast period as well. This is owing to the increasing prevalence of diabetes and the rising number of cataract surgeries worldwide. The American Academy of Ophthalmology projects about 50 million people to be affected by cataract in the U.S. by the end of 2050. This is likely to boost the ophthalmic femtosecond lasers market in the near future.
Technological Advancement in Femtosecond Lasers to Help Market Generate Attractive Revenue
The increasing prevalence of eye diseases is a major factor promoting the growth of the global ophthalmic femtosecond lasers market. The introduction of various techniques to detect various complexities of eye disorders and advancement in femtosecond lasers will also help the market witness better growth opportunities in the future. For instance, the launch of LanSx, an ophthalmic femtosecond laser in 2018 by a considerable player in the eye care solutions and Alcon, a division of Novartis AG will be used for treating intracorneal pockets and rings for presbyopia-correcting inlays. Such innovations are likely to bode well for the global market in the long run.
FDA Approvals for Femtosecond Lasers to Bode Well for Market
Some of the companies operating in the global ophthalmic femtosecond lasers market include:
- Menlo Systems
- Johnson & Johnson Surgical Vision, Inc.
- Bausch & Lomb Incorporated
- IMRA America, Inc.
- LENSAR Inc.
- Ziemer Ophthalmic Systems
- Carl Zeiss Meditec AG
- Novartis AG (Alcon)
Some of the recent development made by companies include:
February’2018 – One of the leading players in femtosecond laser technology, LENSAR Inc., acquired the business unit of Precision Eye Services (PES) Inc.
April’2018– The FDA provided clearance to LENSAR Inc. for their laser system with Streamline IV, for including the creation of corneal pockets and flaps.
Segmentation of the Global Ophthalmic Femtosecond Lasers Market
- Consumables and accessories
- Refractive Surgery
- Cataract Surgery
- Pocket Creation
- Intracorneal Rings
- Incisions & Flap Cuts
By Type of Cells
- Speciality Clinics
- Ambulatory Surgical Centers
- Eye Institutes
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
View Related Reports: